Susceptibility of healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) hybrid immunity to XBB lineage reinfection.

IF 3 4区医学 Q2 INFECTIOUS DISEASES

Infection Control and Hospital Epidemiology Pub Date : 2024-06-01 Epub Date: 2024-02-20 DOI:10.1017/ice.2023.282

Karissa A Whiting, Rebecca Guest, Venkatraman E Seshan, Mini Kamboj

引用次数: 0

Abstract

Among 8,678 vaccinated healthcare personnel (HCP) with previous coronavirus disease 2019 (COVID-19), by August 28, 2023, 909 (10%) had an infection of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron XBB variant. Reinfection risk was comparable irrespective of previous infection type except for the omicron BQ.1 variant. Bivalent vaccination had a protective effect. COVID-19 vaccines remain vital to protect HCP, including those with hybrid immunity.

查看原文本刊更多论文

严重急性呼吸道冠状病毒 2（SARS-CoV-2）混合免疫的医护人员对 XBB 系再感染的敏感性。

在8,678名接种过2019年冠状病毒疾病（COVID-19）疫苗的医护人员（HCP）中，到2023年8月28日，有909人（10%）感染了严重急性呼吸道冠状病毒2（SARS-CoV-2）ogicron XBB变体。除 omicron BQ.1 变体外，无论以前的感染类型如何，再感染风险都相当。二价疫苗具有保护作用。COVID-19 疫苗对保护包括具有混合免疫力在内的高危人群仍然至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Infection Control and Hospital Epidemiology 医学-传染病学

CiteScore

6.40

自引率

6.70%

发文量

289

审稿时长

3-8 weeks

期刊介绍： Infection Control and Hospital Epidemiology provides original, peer-reviewed scientific articles for anyone involved with an infection control or epidemiology program in a hospital or healthcare facility. Written by infection control practitioners and epidemiologists and guided by an editorial board composed of the nation''s leaders in the field, ICHE provides a critical forum for this vital information.